See more : Tobii Dynavox AB (publ) (TDVXF) Income Statement Analysis – Financial Results
Complete financial analysis of MeVis Medical Solutions AG (M3V.DE) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of MeVis Medical Solutions AG, a leading company in the Medical – Healthcare Information Services industry within the Healthcare sector.
- AMTD IDEA Group (HKB.SI) Income Statement Analysis – Financial Results
- Ashford Hospitality Trust, Inc. (AHT-PD) Income Statement Analysis – Financial Results
- Hanjin Transportation Co., Ltd. (002320.KS) Income Statement Analysis – Financial Results
- Accor SA (ACRFF) Income Statement Analysis – Financial Results
- Legend Power Systems Inc. (LPS.V) Income Statement Analysis – Financial Results
MeVis Medical Solutions AG (M3V.DE)
About MeVis Medical Solutions AG
MeVis Medical Solutions AG develops, markets, and sells software for analyzing and evaluating image data to equipment manufacturers of medical devices, providers of medical IT platforms, and clinical end customers in the United States and Europe. The company's clinical focuses are image-based early detection and diagnosis of epidemiologically important diseases, such as breast, lung, liver, and neurological disorders. It offers X-ray modalities, including computed tomography, digital mammography, digital tomosynthesis, magnetic resonance imaging, and digital sonography; and provides services in the field of software programming for medical technology companies, which comprise provision of software developers, product and project managers, application specialists, and test engineers. The company also offers three-dimensional technical visualizations; and interactive online training to enhance the diagnostic skills of clinicians, as well as internet-based special applications in teleradiology. In addition, its services are used for technical visualization and online training. The company was founded in 1992 and is based in Bremen, Germany. MeVis Medical Solutions AG is a subsidiary of Varex Imaging Deutschland AG.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 17.34M | 18.76M | 16.21M | 17.13M | 18.07M | 16.76M | 18.54M | 16.12M | 16.01M | 13.09M | 14.62M | 13.35M | 13.68M | 14.29M | 13.87M | 10.84M | 7.89M | 8.34M |
| Cost of Revenue | 10.34M | 746.56K | 436.85K | 626.21K | 457.01K | 474.00K | 506.00K | 6.15M | 612.00K | 634.00K | 683.00K | 535.00K | 712.00K | 0.00 | 459.00K | 367.00K | 650.00K | 427.00K |
| Gross Profit | 7.00M | 18.02M | 15.78M | 16.50M | 17.62M | 16.28M | 18.03M | 9.97M | 15.40M | 12.46M | 13.93M | 12.81M | 12.97M | 14.29M | 13.41M | 10.48M | 7.24M | 7.92M |
| Gross Profit Ratio | 40.38% | 96.02% | 97.31% | 96.34% | 97.47% | 97.17% | 97.27% | 61.83% | 96.18% | 95.16% | 95.33% | 95.99% | 94.79% | 100.00% | 96.69% | 96.62% | 91.76% | 94.88% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.42M | 3.58M | 3.45M | 3.49M | 4.80M | 4.28M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 442.00K | 444.00K | 730.00K | 684.00K | 548.00K | 157.00K | 242.00K | 0.00 | 805.00K | 338.00K | 398.00K | 533.00K | 0.00 | 690.00K | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 43.00K | 112.00K | 0.00 | 0.00 | 0.00 | 0.00 | 15.00K | 15.00K | 61.00K | 72.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 442.00K | 444.00K | 773.00K | 796.00K | 548.00K | 157.00K | 242.00K | 1.99M | 820.00K | 353.00K | 459.00K | 605.00K | 0.00 | 690.00K | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Expenses | 116.96K | 11.20M | 9.98M | 9.84M | 9.93M | 9.20M | 9.76M | 270.67K | 9.77M | 8.17M | 9.41M | 9.20M | 14.61M | 19.03M | 11.78M | 9.81M | 6.75M | 3.17M |
| Operating Expenses | 558.96K | 11.64M | 10.75M | 10.63M | 10.47M | 9.35M | 10.00M | 5.17M | 10.59M | 8.53M | 9.87M | 9.80M | 14.61M | 19.72M | 11.78M | 9.81M | 6.75M | 3.17M |
| Cost & Expenses | 10.90M | 12.39M | 11.19M | 11.26M | 10.93M | 9.83M | 10.51M | 11.33M | 11.20M | 9.16M | 10.55M | 10.34M | 15.32M | 19.72M | 12.24M | 10.18M | 7.40M | 3.60M |
| Interest Income | 110.64K | 177.92K | 161.79K | 301.24K | 169.31K | 158.00K | 159.00K | 60.00K | 165.00K | 213.00K | 101.00K | 64.00K | 112.00K | 389.00K | 598.00K | 1.05M | 198.00K | 66.00K |
| Interest Expense | 42.82K | 3.85K | 10.82K | 11.73K | 9.84K | 76.00K | 77.00K | 0.00 | 66.00K | 62.00K | 148.00K | 382.00K | 346.00K | 712.00K | 996.00K | 321.00K | 137.00K | 330.00K |
| Depreciation & Amortization | 95.84K | 93.05K | 125.51K | 167.51K | 256.03K | 324.26K | 1.22M | 1.76M | 1.94M | 1.70M | 2.15M | 2.98M | 6.06M | 8.88M | 2.84M | 1.09M | 443.00K | 253.00K |
| EBITDA | 5.17M | 7.97M | 5.38M | 5.97M | 8.41M | 8.03M | 7.85M | 6.31M | 6.77M | 6.35M | 5.91M | 5.63M | 3.54M | 3.97M | 5.01M | 4.12M | 1.07M | 5.06M |
| EBITDA Ratio | 29.83% | 42.50% | 33.15% | 34.87% | 46.60% | 50.23% | 45.64% | 40.63% | 44.50% | 52.35% | 41.90% | 42.85% | 25.51% | 27.88% | 36.09% | 37.98% | 13.52% | 60.66% |
| Operating Income | 6.44M | 7.88M | 5.25M | 5.81M | 8.17M | 6.69M | 7.96M | 4.79M | 4.47M | 3.89M | 4.03M | 2.98M | -1.64M | -5.43M | 1.63M | 665.00K | 487.00K | 4.48M |
| Operating Income Ratio | 37.16% | 42.00% | 32.38% | 33.89% | 45.18% | 39.95% | 42.94% | 29.73% | 27.91% | 29.72% | 27.54% | 22.29% | -12.00% | -37.97% | 11.77% | 6.13% | 6.17% | 53.67% |
| Total Other Income/Expenses | -1.41M | 1.41M | -396.38K | -11.80K | 1.01M | 563.00K | 2.13M | -236.01K | 483.00K | 1.05M | -210.00K | -616.00K | -1.27M | -180.00K | -465.00K | 2.04M | -319.00K | 0.00 |
| Income Before Tax | 5.03M | 7.88M | 4.63M | 5.79M | 8.16M | 7.26M | 7.17M | 4.56M | 4.95M | 4.94M | 3.82M | 2.36M | -2.92M | -5.61M | 1.17M | 2.71M | 487.00K | 4.48M |
| Income Before Tax Ratio | 29.03% | 41.98% | 28.56% | 33.82% | 45.13% | 43.30% | 38.66% | 28.27% | 30.93% | 37.77% | 26.11% | 17.67% | -21.31% | -39.23% | 8.42% | 24.95% | 6.17% | 53.67% |
| Income Tax Expense | 114.18K | 87.11K | 85.00K | 90.48K | 85.00K | 86.00K | 1.55M | 3.04M | -1.78M | 1.23M | 135.00K | 195.00K | 1.18M | 2.74M | 770.00K | 592.00K | 355.00K | 1.54M |
| Net Income | 4.92M | 7.79M | 4.55M | 5.70M | 8.07M | 7.17M | 5.62M | 4.57M | 6.74M | 3.71M | 3.68M | 2.16M | -4.09M | -8.35M | 398.00K | 2.11M | 132.00K | 2.94M |
| Net Income Ratio | 28.37% | 41.52% | 28.04% | 33.30% | 44.66% | 42.79% | 30.32% | 28.33% | 42.06% | 28.36% | 25.18% | 16.21% | -29.92% | -58.42% | 2.87% | 19.49% | 1.67% | 35.18% |
| EPS | 2.70 | 4.28 | 2.50 | 3.13 | 4.43 | 3.94 | 3.09 | 2.51 | 3.76 | 2.16 | 2.14 | 1.26 | -2.38 | -4.89 | 0.23 | 1.21 | 0.17 | 5.44 |
| EPS Diluted | 2.70 | 4.28 | 2.50 | 3.13 | 4.43 | 3.94 | 3.09 | 2.48 | 3.72 | 2.16 | 2.14 | 1.26 | -2.38 | -4.89 | 0.23 | 1.21 | 0.17 | 5.44 |
| Weighted Avg Shares Out | 1.82M | 1.82M | 1.82M | 1.82M | 1.82M | 1.82M | 1.82M | 1.82M | 1.79M | 1.72M | 1.72M | 1.72M | 1.72M | 1.71M | 1.70M | 1.74M | 769.58K | 540.00K |
| Weighted Avg Shares Out (Dil) | 1.82M | 1.82M | 1.82M | 1.82M | 1.82M | 1.82M | 1.82M | 1.84M | 1.81M | 1.72M | 1.72M | 1.72M | 1.72M | 1.71M | 1.70M | 1.74M | 769.58K | 540.00K |
Source: https://incomestatements.info
Category: Stock Reports